Floatz logo

ELCUBRAGISTAT

Post Herpetic Neuralgia

Abide TherapeuticsSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Post Herpetic Neuralgia cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Seoul National University Hospital
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB
Pregabalin
Neurodawn Pharmaceutical Co., Ltd.
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of Medicine and Pharmacy at Ho Chi Minh City
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB

View all 50 →

Same molecule, other indications

ELCUBRAGISTAT is also rated in:

transverse myelitisDormant
CC
Indicative ·
47 / 100
View asset →
Longitudinally Extensive Transverse MyelitisDormant
CC
Indicative ·
47 / 100
View asset →
diabetic neuropathyDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →